US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Diagnostics: market research reports

Diagnostics refers to the investigation and identification of disease states in medicine. The modern diagnostic industry generally falls into two broad categories: in vitro diagnostics (from the Latin meaning "in glass") and in vivo diagnostics (from the Latin meaning "in the living"). In vitro diagnostics involves the removal samples of tissue such as blood, saliva, biopsy samples from a living organism for examination in the laboratory setting, whereas in vivo diagnostics involves observing and testing tissue and function in a living organism—techniques such as medical imaging (x-rays, magnetic resonance, computed tomography, etc.) and monitoring like electrocardiography, electroencephalography, etc.).

The in vitro diagnostics industry is a near $50 billion sector that includes the manufacture of tests ranging from over-the-counter at-home kits, such as pregnancy tests, to highly sophisticated molecular (or nucleic acid) tests. In addition to the test elements (the reagents), the laboratory market that the IVD industry serves also includes sales of the equipment used to handle and analyze results. These systems include automated and high-throughput analyzers and readers to assist in handling the large volume of tests that typical hospitals and reference labs.
The medical imaging sector is a technology-intensive area of diagnostics that has traditionally been consolidated in the hands of a few large corporations. The sector is driven by innovation in both equipment (miniaturization, portability, integration with IT infrastructures) and in clinical and research application. Improvements in computer enhancement and in new contrast media as well as the advent of high-tech molecular imaging techniques has broadened the range of conditions that in vivo imaging can address.
  • In Vitro Diagnostics (4470)
  • Medical Imaging (2081)
RSS Feeds

Diagnostics market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
In-Vitro Diagnostic Substance Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition]
7/29/2014 | published by: Supplier Relations US, LLC
... and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 175-page report includes the most recent information ...  |  read more...
USD 799
Irradiation Apparatus Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition]
7/29/2014 | published by: Supplier Relations US, LLC
... inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. This 170-page report includes the most recent information on ...  |  read more...
USD 599
Global Medical Biosensors Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... HealthCare AG, LifeScan Inc., F. Hoffmann-La Roche Ltd. , Acethem , Acon , Biotest Medical , FICO, Contec Medical , Convergent, Integrity , I-sens , Nipro Diagnostics , Optiscan , TaiDoc , Urit Medical Commenting ...  |  read more...
USD 2,500
LipoScience, Inc. (LPDX) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Analysis of the Global In Vitro Diagnostics Market
7/22/2014 | published by: Frost & Sullivan
... global IVD market size was $?? billion in 2013; it is expected to reach $?? billion in 2017, growing at a compound annual growth rate (CAGR) of ??%. Global trends summary: oThe United States and ...  |  read more...
USD 10,000
Menssana Research, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... breast cancer, heart transplant rejection, kidney disease, ischemic heart disease, diabetes mellitus, and development of the next-generation BCA. Menssana has developed a point-of-care breath-testing system, BreathLink, which collects concentrates and analyzes a breath sample. It ...  |  read more...
USD 750
Toshiba Medical Systems Corporation - Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
USD 125
Trinity Biotech Plc (TRIB) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... that detect infectious diseases, HbA1c for diabetes monitoring and diagnosis, and clinical chemistry. Its Point-of-care products are for testing the presence of HIV antibodies. The products are used for the detection of autoimmune, sexually transmitted ...  |  read more...
USD 750
Myriad RBM (formerly Rules:Based Medicine, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Myriad RBM (formerly Rules-Based Medicine, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Hologic, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Hologic, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Siemens Healthcare Diagnostics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Siemens Healthcare Diagnostics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
QIAGEN N.V. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' QIAGEN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Gen:Probe Incorporated : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Gen-Probe Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Epigenomics AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Epigenomics AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Pacific Biosciences of California, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Pacific Biosciences of California, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
BioHelix Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... kit, IsoAmpII tHDA kit, IsoAmpIII tHDA kit, and BESt Cassette, among others. BioHelix offers primer navigator series products. The company’s helicases include thermostable DNA helicase, and mesophilic DNA helicase. It develops cutting-edge nucleic acid technologies ...  |  read more...
USD 750
DioGenix, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... codon replacement frequencies in the variable region of immunoglobulin heavy chain genes in B cells. DGx uses next-generation sequencing to measure DNA mutations. The company offers products for the diagnosis and monitoring of neurological and ...  |  read more...
USD 750
GeneFluidics Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... GeneFluidics offers systems operation to user to introduce a raw sample, such as whole blood, urine, saliva, or water to a disposable cartridge and inserts cartridge into a reader instrument for test results. The company ...  |  read more...
USD 750
Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... consists of Oncotype DX breast cancer test,Oncotype DX colon cancer test, and Oncotype DX prostate cancer test. Its product pipeline helps optimize the treatment of urologic cancers including prostate, bladder and kidney cancers, as well ...  |  read more...
USD 750
Hycor Biomedical Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... EIA system, ELISA microplate assay kits, 288 plus system, reagents, allergy products, urinalysis products, and serology reagents. Hycor provides serology assays for detection of antibodies to target organisms. The company provides organ-specific, systemic, ENA-6 tests, ...  |  read more...
USD 750
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... are today 229 companies plus partners developing 291 nucleic acid therapy drugs in 636 developmental projects in cancer. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,746
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... several hallmarks of cancer such as cell growth and proliferation, angiogenesis, and bioenergetics. Since mTOR acts as a neoplastic switch that is frequently turned on by many mutations found in cancer, inhibition of mTOR may ...  |  read more...
USD 6,746
AltheaDx, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... next-gen sequencing, quantitative PCR, mutation scanning, data analysis, and therapeutic siRNA. AltheaDx provides clinical trial services, such as predictive drug response, patient stratification, efficacy monitoring, disease staging, and vaccine and gene therapy. The company partners ...  |  read more...
USD 750
Luminex Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Luminex Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Cepheid – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cepheid Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10